Ozlem Oyardi
Overview
Explore the profile of Ozlem Oyardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hacioglu M, Oyardi O, Kirinti A
Z Naturforsch C J Biosci
. 2021 Apr;
76(11-12):443-450.
PMID: 33915040
spp. can form biofilms on mucosal surfaces and epithelial cells as well as on devices implanted in the body such as catheters and dentures, which are thought to underlie the...
12.
Muftah H, Ozcelik B, Oyardi O, Kutluk I, Orhan N
Pak J Pharm Sci
. 2021 Feb;
33(4):1443-1449.
PMID: 33583773
The objective of this study was to evaluate the in vitro bioactivity of the active ingredient in selected antimicrobial magistral drug formulations and plant extracts used in folk medicine, comparatively....
13.
Oyardi O, Savage P, Erturan Z, Bozkurt-Guzel C
J Antimicrob Chemother
. 2020 Oct;
76(2):443-450.
PMID: 33094334
Background: Stenotrophomonas maltophilia is a Gram-negative bacterium resistant to several antibiotics and its prevalence in cystic fibrosis (CF) patients is increasing. Objectives: To evaluate the effects of ceragenins, non-peptide mimics...
14.
Dosler S, Hacioglu M, Nur Yilmaz F, Oyardi O
PeerJ
. 2020 Jul;
8:e9419.
PMID: 32612893
During the contact lens (CL) usage, microbial adhesion and biofilm formation are crucial threats for eye health due to the development of mature biofilms on CL surfaces associated with serious...
15.
Hacioglu M, Oyardi O, Bozkurt-Guzel C, Savage P
J Antibiot (Tokyo)
. 2020 Mar;
73(7):455-462.
PMID: 32203127
Multispecies biofilms, in which both fungus and bacteria species can be present, play a significant role in persistent infections, and new therapeutic options are needed against them. In this study,...
16.
Bozkurt-Guzel C, Inci G, Oyardi O, Savage P
Curr Microbiol
. 2020 Mar;
77(8):1419-1428.
PMID: 32189050
Acinetobacter baumannii is an emerging opportunistic pathogen that primarily infects critically ill patients in nosocomial settings and there is a need for identifying new alternative therapeutic agents against these organisms....
17.
Hulsdunker J, Thomas O, Haring E, Unger S, Gonzalo Nunez N, Tugues S, et al.
Proc Natl Acad Sci U S A
. 2019 Sep;
116(41):20700-20706.
PMID: 31527267
Microbial invasion into the intestinal mucosa after allogeneic hematopoietic cell transplantation (allo-HCT) triggers neutrophil activation and requires antibiotic interventions to prevent sepsis. However, antibiotics lead to a loss of microbiota...
18.
Bozkurt Guzel C, Oyardi O, Savage P
J Chemother
. 2019 Jan;
30(6-8):332-337.
PMID: 30663553
Ceragenins, a novel family of antibiotics, are cationic derivatives of cholic acid and display broad-spectrum antimicrobial activities. Multiple ceragenins have been synthesized and studied, and most published data are with...
19.
Suntar I, Oyardi O, Akkol E, Ozcelik B
Pharm Biol
. 2015 Oct;
54(6):1065-70.
PMID: 26510970
Context: One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica. Objective: The present study investigates...